901 related articles for article (PubMed ID: 19736620)
1. The future therapeutic potential of histone demethylases: A critical analysis.
Natoli G; Testa G; De Santa F
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
[TBL] [Abstract][Full Text] [Related]
2. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
[TBL] [Abstract][Full Text] [Related]
3. Targeting histone lysine demethylases by truncating the histone 3 tail to obtain selective substrate-based inhibitors.
Lohse B; Nielsen AL; Kristensen JB; Helgstrand C; Cloos PA; Olsen L; Gajhede M; Clausen RP; Kristensen JL
Angew Chem Int Ed Engl; 2011 Sep; 50(39):9100-3. PubMed ID: 21919140
[No Abstract] [Full Text] [Related]
4. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
Krishnan S; Horowitz S; Trievel RC
Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
[TBL] [Abstract][Full Text] [Related]
6. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.
Klose RJ; Yamane K; Bae Y; Zhang D; Erdjument-Bromage H; Tempst P; Wong J; Zhang Y
Nature; 2006 Jul; 442(7100):312-6. PubMed ID: 16732292
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-histone substrates for JMJD2A-C histone demethylases.
Ponnaluri VK; Vavilala DT; Putty S; Gutheil WG; Mukherji M
Biochem Biophys Res Commun; 2009 Dec; 390(2):280-4. PubMed ID: 19799855
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylation and steroid receptor function in cancer.
Stratmann A; Haendler B
Mol Cell Endocrinol; 2012 Jan; 348(1):12-20. PubMed ID: 21958694
[TBL] [Abstract][Full Text] [Related]
10. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
12. Targeting the JMJD2A histone lysine demethylase.
Wilson JR
Nat Struct Mol Biol; 2007 Aug; 14(8):682-4. PubMed ID: 17676028
[No Abstract] [Full Text] [Related]
13. Histone lysine demethylases: emerging roles in development, physiology and disease.
Shi Y
Nat Rev Genet; 2007 Nov; 8(11):829-33. PubMed ID: 17909537
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
15. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins.
Rathert P; Dhayalan A; Ma H; Jeltsch A
Mol Biosyst; 2008 Dec; 4(12):1186-90. PubMed ID: 19396382
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms.
Martinez ED; Gazdar AF
Epigenomics; 2016 Mar; 8(3):313-6. PubMed ID: 26918824
[No Abstract] [Full Text] [Related]
17. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
18. Targeting protein lysine methylation and demethylation in cancers.
He Y; Korboukh I; Jin J; Huang J
Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):70-9. PubMed ID: 22194015
[TBL] [Abstract][Full Text] [Related]
19. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
20. Regulation and function of H3K9 methylation.
Shinkai Y
Subcell Biochem; 2007; 41():337-50. PubMed ID: 17484135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
